Importance The COVID-19 pandemic has been associated with a transient decrease in
bronchiolitis hospitalizations compared with prepandemic patterns, but current effects�…

Respiratory syncytial virus (RSV) is the greatest contributor to lower respiratory tract
infections (LRTI) in children less than 5 years of age and the leading cause for infant�…

The burden of respiratory syncytial virus (RSV) disease is widely recognized. Main risk
factors for severe disease, such as extreme ages, chronic cardiopulmonary conditions, and�…

Importance After the COVID-19 pandemic, there was a surge of pediatric respiratory
syncytial virus (RSV) infections, but national data on hospitalization and intensive care unit�…

Importance Respiratory syncytial virus (RSV) transmission was disrupted worldwide
following the COVID-19 pandemic, and further study is required to better understand these�…

OBJECTIVES: Multiple viral respiratory epidemics occurred concurrently in 2022 but their
true extent is unclear. To aid future surge planning efforts, we compared epidemiology and�…

Background Respiratory syncytial virus (RSV) is one of the leading causes of hospitalisation,
morbidity, and mortality due to respiratory infection in the first years of life. This longitudinal�…

ABSTRACT Respiratory Syncytial Virus poses a significant global public health threat,
particularly affecting infants aged less than one year of age. Recently, two forms of passive�…

The efforts to prevent respiratory syncytial virus (RSV) infection in infants span over half a
century. RSV vaccine development began in the 1960s, and it confronted a significant�…

Objectives: To investigate the perception and willingness of pregnant women and their
partners to accept maternal vaccination or neonatal immunization against respiratory�…